Sonidegib
Also called Erismodegib, NVP-LDE225, Odomzo
Part of the metabolic pathway of Sonidegib. See the timeline on the metabolic highway.
Enzymes that break it down: CYP3A. Wikipedia’s drug infobox says: “Liver (CYP3A)” (revision 1372709097).
Overview
Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.[1] WP
Sonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism).[2]
Drug class
Antineoplastic WP
From the Wikipedia article's infobox.
Pharmacology
Pharmacology
Sonidegib is administered by mouth. Common side effects include muscle spasms, hair loss, fatigue, abdominal pain, nausea, headache, and weight loss.[1] WP
Sonidegib binds to and inhibits smoothened to inhibit activation of the Hedgehog pathway. Sonidegib is primarily metabolized by CYP3A and is eliminated hepatically.[1] WP
Chemistry
- Formula
- C26H26F3N3O3 PC
- CAS number
- 956697-53-3 PC
- Molar mass (g/mol)
- 485.5 PC
- IUPAC name (computed by PubChem)
- N-
[6- PC[(2R, 6S) - 2, 6- dimethylmorpholin- 4- yl] - 3- pyridinyl] - 2- methyl- 3- [4- (trifluoromethoxy) phenyl] benzamide - SMILES
- C[C@@H]
1CN(C[C@@H] PC(O1) C) C2=NC=C(C=C2) NC(=O) C3=CC=CC(=C3C) C4=CC=C(C=C4) OC(F) (F) F - InChIKey
- VZZJRYRQSPEMTK-
CALCHBBNSA- PCN - PubChem CID
- 24775005
Harm reduction information
No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.
User reports
Erowid erowid.org
ListingsBluelight bluelight.org
ListingsReddit reddit.com
ListingsPop culture
No references added yet.
Add a reference
Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.
Opens when accounts launch.
Sources
- Journal / agency Odomzo- sonidegib capsule. 29 May 2019
- Journal / agency LDE225 - PubChem
- Journal / agency Pan S, Wu X, Jiang J, Gao W, Wan Y, Cheng D, Han D, Liu J, Englund NP, Wang Y, Peukert S, Miller-Moslin K, Yuan J, Guo R, Matsumoto M, Vattay A, Jiang Y, Tsao J, Sun F, Pferdekamper AC, Dodd S, Tuntland T, Maniara W, Kelleher JF, Yao YM, Warmuth M, Williams J, Dorsch M. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. ACS Medicinal Chemistry Letters. June 2010. doi:10.1021/ml1000307 · PMID 24900187 · PMC4007689
Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.